title: Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.
abstract: Cytomegalovirus (CMV) is a β-herpesvirus that establishes a lifelong latent or persistent infection. A hallmark of chronic CMV infection is the lifelong persistence of large numbers of virus-specific CD8+ effector/effector memory T cells, a phenomenon called "memory inflation". How the virus continuously stimulates these T cells without being eradicated remains an enigma. The prevailing view is that CMV establishes a low grade "smoldering" infection characterized by tiny bursts of productive infection which are rapidly extinguished, leaving no detectable virus but replenishing the latent pool and leaving the immune system in a highly charged state. However, since abortive reactivation with limited viral gene expression is known to occur commonly, we investigated the necessity for virus reproduction in maintaining the inflationary T cell pool. We inhibited viral replication or spread in vivo using two different mutants of murine CMV (MCMV). First, famcyclovir blocked the replication of MCMV encoding the HSV Thymidine Kinase gene, but had no impact on the CD8+ T cell memory inflation once the infection was established. Second, MCMV that lacks the essential glycoprotein L, and thus is completely unable to spread from cell to cell, also drove memory inflation if the virus was administered systemically. Our data suggest that CMV which cannot spread from the cells it initially infects can repeatedly generate viral antigens to drive memory inflation without suffering eradication of the latent genome pool.
authors: Department of Molecular Microbiology and Immunology, Oregon Health and Sciences University, Portland, Oregon, United States of America. christopher.snyder@jefferson.edu
authors: Christopher M
authors: CM
authors: Snyder
authors: Kathy S
authors: KS
authors: Cho
authors: Elizabeth L
authors: EL
authors: Bonnett
authors: Jane E
authors: JE
authors: Allan
authors: Ann B
authors: AB
authors: Hill
mesh_terms: D000212:Acyclovir / Q000494:pharmacology; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000494:pharmacology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005786:Gene Expression Regulation; D006566:Herpesviridae Infections / Q000276:immunology*; D017874:Immediate-Early Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D007156:Immunologic Memory; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D018146:Muromegalovirus / Q000378:metabolism / Q000472:pathogenicity* / Q000502:physiology; D010641:Phenotype; D013937:Thymidine Kinase / Q000235:genetics; D017735:Virus Latency / Q000276:immunology; D014779:Virus Replication
chemical_list: D000956:Antigens, Viral; D000998:Antiviral Agents; C088646:IE3 protein, cytomegalovirus; D017874:Immediate-Early Proteins; D013937:Thymidine Kinase; D000212:Acyclovir